Quidel | QDEL - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 8.52B 1.01B 2025-12
Agilent USD 1.76B 31M 2025-12
Avanos Medical USD 89.8M 19.3M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Cerus USD 15.67M 321K 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Danaher USD 4.62B 3.09B 2025-12
Haemonetics USD 363.37M 66.94M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Illumina USD 1.42B 368M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Merit Medical Systems USD 446.4M 53.95M 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
Neogen USD 159.9M 14.56M 2025-12
OraSure Technologies USD 199.28M 17.2M 2025-12
Pacific Biosciences Of California USD 279.51M 223.04M 2025-12
Quidel USD 169.8M 71.7M 2025-12
Revvity USD 919.86M 11.53M 2025-12
STAAR Surgical USD 153.15M 23M 2025-12
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Waters USD 587.83M 128.71M 2025-12